A few days after U.S. Secretary of State Hillary Clinton outlined a vision for achieving an AIDS-free generation through sustained funding and global efforts, a new report cites a drop in international financial support for HIV vaccine research in 2010 compared with previous years.
“Between 2009 and 2010, overall investment in HIV vaccine [research and development] dropped [1 percent] from $868 million to $859 million,” according to the report by the International AIDS Vaccine Initiative.
The report does note the 1 percent drop still reflects a commitment from donors, who are experiencing domestic financial woes, to global efforts to the development of an HIV vaccine.
The HIV vaccine research field can expect certain challenges in the coming years, considering trends in how the field is funded, the report says. It notes the bulk of the funding comes from a handful of major donors — a setup that creates the risk of a significant negative impact should key donors such as the United States and the Bill and Melinda Gates Foundation cut back their assistance.
The report also highlights the need for prioritized programmatic support, continued funding for basic and discovery research to maintain the health of the HIV vaccine pipeline, and development of new innovations and technologies to aid existing research.
Read more development aid news online, and subscribe to The Development Newswire to receive top international development headlines from the world’s leading donors, news sources and opinion leaders — emailed to you FREE every business day.